JAGX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Jaguar Health Inc (JAGX) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows weak financial performance, no positive trading signals, and lacks any significant catalysts to drive growth or recovery. Additionally, the technical indicators and recent price trends do not suggest a favorable entry point.
The MACD histogram is positive at 0.0433 and expanding, indicating mild bullish momentum. However, the RSI_6 at 78.667 is in the neutral zone, and moving averages are converging, showing no clear trend. The stock is trading below its previous close, and the pre-market, regular market, and post-market changes are all negative, indicating bearish sentiment. Key resistance levels are at 0.843 and 0.923, with support levels at 0.713 and 0.584.
NULL identified. There is no recent news, no significant hedge fund or insider trading activity, and no congress trading data available.
The stock has experienced consistent price declines in pre-market, regular market, and post-market trading. Financial performance is weak, with declining revenue, net income, and EPS. No significant trading trends or positive sentiment from hedge funds or insiders.
In Q3 2025, revenue dropped to $3,083,000 (-0.80% YoY), net income dropped to -$9,502,000 (-3.57% YoY), and EPS dropped significantly to -6.28 (-76.11% YoY). Gross margin increased slightly to 82.74 (+0.18% YoY), but overall financial performance remains poor.
No data available for analyst ratings or price target changes.
